嗜麦芽寡养单胞菌感染管理与临床治疗研究进展  

Progress of study on management and clinical treatment of Stenotrophomonas maltophilia infections

作　　者：赵进[1] 刘运喜[2] 倪文涛[1] 王睿[3] 刘又宁[1] 

机构地区：[1]解放军总医院呼吸科,北京100853 [2]解放军总医院感染管理与疾病控制科,北京100853 [3]解放军总医院药物临床研究中心,北京100853

出　　处：《中华医院感染学杂志》2017年第10期2397-2400,共4页Chinese Journal of Nosocomiology

摘　　要：嗜麦芽寡养单胞菌(Sm)在免疫缺陷患者和重症监护室患者可以引起严重的感染,是医院感染重要的病原体;Sm在医院环境中广泛存在,而且对多种临床常用的抗菌药物和消毒剂天然耐药,给感染管理和临床治疗都带来了巨大的挑战;因此,笔者总结了医院内Sm感染的危险因素与高危人群、毒力因子与耐药机制以及最新的感染管理与临床治疗策略,为Sm感染的治疗和预防控制提供参考。As a leading species of pathogen causing nosocomial infections,Stenotrophomonas maltophilia may result in severe infections in immunocompromised patients and intensive care unit patients.S.maltophilia is prevalent in hospital environment and shows natural resistance to a variety of commonly used antibiotics and disinfectants,which brings great challenge to the clinical control and treatment of the infections.The authors of the paper interpret the risk factors for the nosocomial S.maltophilia infections,define the high-risk populations,virulence factors,and drug resistance mechanisms,and introduce the latest strategies for clinical control and treatment of infections so as to provide guidance for treatment,control,and prevention of the S.maltophilia infections.

关 键 词：嗜麦芽寡养单胞菌 医院感染 危险因素 管理 治疗 

分 类 号：R378[医药卫生—病原生物学]